251 related articles for article (PubMed ID: 25268204)
1. [Modern anti-cancer therapy: current state and future developments].
Bokemeyer C; Hiddemann W
Dtsch Med Wochenschr; 2014 Oct; 139(41):2067. PubMed ID: 25268204
[No Abstract] [Full Text] [Related]
2. [Targeted therapy: old and new possibilities].
Hochhaus A; Lüftner D; Mackensen A
Onkologie; 2013; 36 Suppl 5():2-11. PubMed ID: 23921800
[No Abstract] [Full Text] [Related]
3. Development trends for monoclonal antibody cancer therapeutics.
Reichert JM; Valge-Archer VE
Nat Rev Drug Discov; 2007 May; 6(5):349-56. PubMed ID: 17431406
[TBL] [Abstract][Full Text] [Related]
4. Optimising translational oncology in clinical practice: strategies to accelerate progress in drug development.
Stahel R; Bogaerts J; Ciardiello F; de Ruysscher D; Dubsky P; Ducreux M; Finn S; Laurent-Puig P; Peters S; Piccart M; Smit E; Sotiriou C; Tejpar S; Van Cutsem E; Tabernero J
Cancer Treat Rev; 2015 Feb; 41(2):129-35. PubMed ID: 25533737
[TBL] [Abstract][Full Text] [Related]
5. Targeted drugs in combination with radiotherapy for the treatment of solid tumors: current state and future developments.
Selzer E; Kornek G
Expert Rev Clin Pharmacol; 2013 Nov; 6(6):663-76. PubMed ID: 24164614
[TBL] [Abstract][Full Text] [Related]
6. Personalizing oncology: perspectives and prospects.
Mendelsohn J
J Clin Oncol; 2013 May; 31(15):1904-11. PubMed ID: 23589547
[TBL] [Abstract][Full Text] [Related]
7. X chemotherapy, myth and realities.
Thomas M; Pavithran K
J Indian Med Assoc; 2005 Sep; 103(9):489-90, 492, 494. PubMed ID: 16493871
[TBL] [Abstract][Full Text] [Related]
8. Targeted immunotherapies overtaking emerging oncology market value based growth.
Jakovljevic MB
J BUON; 2015; 20(1):350-1. PubMed ID: 25778340
[No Abstract] [Full Text] [Related]
9. Targeted and tailored therapy in hemato-oncology: vision for the 21st century.
Shpilberg O; Ben-Bassat I; Raanani P
Isr Med Assoc J; 2006 Dec; 8(12):843-4. PubMed ID: 17214100
[TBL] [Abstract][Full Text] [Related]
10. New targets and targeted drugs for the treatment of cancer: an outlook to pediatric oncology.
Rossig C; Juergens H; Berdel WE
Pediatr Hematol Oncol; 2011 Oct; 28(7):539-55. PubMed ID: 21936619
[TBL] [Abstract][Full Text] [Related]
11. [Advances in medical oncology].
Shi YK
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):305-10. PubMed ID: 16900620
[TBL] [Abstract][Full Text] [Related]
12. [New drugs in oncology: benefits, risks and challenges].
Cella D; Vervölgyi V; Wörmann B
Onkologie; 2013; 36 Suppl 5():12-9. PubMed ID: 23921801
[No Abstract] [Full Text] [Related]
13. The RACE to accelerate drug development for children with cancer.
Pearson ADJ; Karres D; Reaman G; DuBois SG; Knox L; Scobie N; Vassal G
Lancet Child Adolesc Health; 2020 Oct; 4(10):714-716. PubMed ID: 32822672
[No Abstract] [Full Text] [Related]
14. ASCO 2011: broadening the horizons of cancer research.
Crane K
J Natl Cancer Inst; 2011 Jul; 103(13):999-1001. PubMed ID: 21693729
[No Abstract] [Full Text] [Related]
15. Targeted biopharmaceuticals for cancer treatment.
Zhou L; Xu N; Sun Y; Liu XM
Cancer Lett; 2014 Oct; 352(2):145-51. PubMed ID: 25016064
[TBL] [Abstract][Full Text] [Related]
16. [Dermatology -- the most progressive discipline in medicine].
Röcken M
J Dtsch Dermatol Ges; 2015 Jul; 13(7):617-9. PubMed ID: 26110720
[No Abstract] [Full Text] [Related]
17. [Status quo and prospects for systemic therapy of atopic dermatitis. Biologics ante portas].
Biedermann T; Werfel T
Hautarzt; 2015 Feb; 66(2):108-13. PubMed ID: 25645542
[TBL] [Abstract][Full Text] [Related]
18. The next generation of antibody-drug conjugates comes of age.
Beck A; Haeuw JF; Wurch T; Goetsch L; Bailly C; Corvaïa N
Discov Med; 2010 Oct; 10(53):329-39. PubMed ID: 21034674
[TBL] [Abstract][Full Text] [Related]
19. [Targeted based therapies in metastatic breast cancer: future evolution].
Belmondo L; Montana M; Curti C; Crozet M; Rathelot P; Penot-Ragon C; Vanelle P
Therapie; 2012; 67(6):491-503. PubMed ID: 23249575
[TBL] [Abstract][Full Text] [Related]
20. Advanced non-small-cell lung cancer: new data, therapy choices, and challenging decisions.
Sandler AB
Oncology (Williston Park); 2006 May; 20(6):626-8. PubMed ID: 16773846
[No Abstract] [Full Text] [Related]
[Next] [New Search]
